BALCX
Price
$36.31
Change
-$0.05 (-0.14%)
Updated
Nov 13 closing price
JCAVX
Price
$10.49
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
Ad is loading...

BALCX vs JCAVX

Header iconBALCX vs JCAVX Comparison
Open Charts BALCX vs JCAVXBanner chart's image
American Funds American Balanced C
Price$36.31
Change-$0.05 (-0.14%)
VolumeN/A
CapitalizationN/A
JHFunds2 Capital Appreciation Value NAV
Price$10.49
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
BALCX vs JCAVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALCX vs. JCAVX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a StrongBuy and JCAVX is a Buy.

FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 240B vs. JCAVX (1.18B). JCAVX pays higher dividends than BALCX: JCAVX (2.19) vs BALCX (1.59). BALCX was incepted earlier than JCAVX: BALCX (24 years) vs JCAVX (14 years). BALCX is a more actively managed with annual turnover of: 171.00 vs. JCAVX (88.00). JCAVX has a lower initial minimum investment than BALCX: JCAVX (0) vs BALCX (250). BALCX annual gain was more profitable for investors over the last year : 23.86 vs. JCAVX (20.84). BALCX return over 5 years is better than : 33.79 vs. JCAVX (-5.80).
BALCXJCAVXBALCX / JCAVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years14 years-
Gain YTD15.02914.613103%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets240B1.18B20,374%
Annual Yield % from dividends1.592.1972%
Returns for 1 year23.8620.84114%
Returns for 3 years10.30-14.54-71%
Returns for 5 years33.79-5.80-582%
Returns for 10 years47.46-4.89-970%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTVT13.910.98
+7.58%
vTv Therapeutics
STBA43.22-0.19
-0.44%
S&T Bancorp
VMI345.23-3.06
-0.88%
Valmont Industries
BIDU84.80-3.48
-3.94%
Baidu
TCRX5.43-0.27
-4.74%
TScan Therapeutics